Filing Flows › LifeMD (LFMD) › Q1 2026 › vs Q1 2025
LifeMD (LFMD) Q1 2026 vs Q1 2025 (year over year)
LifeMD's revenue fell $725K (-1%) from $50.9M in Q1 2025 to $50.2M in Q1 2026. The biggest changes: Telehealth −$1.0M (-5%); Telehealth Subscription Revenue +$280K (+0.9%).
LifeMD, Q1 2026: revenue $50.2M (-1% year over year), operating margin -17.8%, net loss $8.9M, operating cash flow $445K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Telehealth Subscription Revenue | $30.4M | $30.1M | $280K | +0.9% |
| Telehealth | $19.8M | $20.8M | −$1.0M | -5% |
| Revenue | $50.2M | $50.9M | −$725K | -1% |
| Net loss | $8.9M | −$348K | $9.2M | — |
| Costs & expenses | $59.1M | $52.9M | $6.2M | +12% |
| Operating costs | $59.1M | $52.1M | $7.0M | +13% |
| Cost of revenue | $5.9M | $8.1M | −$2.2M | -27% |
| Sales & marketing | $29.9M | $22.3M | $7.6M | +34% |
| General & admin | $15.2M | $14.3M | $836K | +6% |
| Other operating costs | $8.1M | $7.3M | $795K | +11% |
| Operating cash sources | $9.3M | $2.7M | $6.6M | +243% |
| Depreciation & amortization | $321K | $162K | $159K | +98% |
| Share-based compensation | $1.4M | $2.5M | −$1.1M | -43% |
| Working capital & other | $7.5M | $10K | $7.5M | 773× |
| Net loss absorbed | $8.9M | −$348K | $9.2M | — |
| Operating cash flow | $445K | $3.1M | −$2.6M | -86% |
| Capital expenditures | $2.0M | $2.0M | $0 | 0% |
| Negative free cash flow (OCF − capex) | $1.6M | −$1.1M | $2.6M | — |
Questions
How much did LifeMD's revenue grow year over year in Q1 2026?
LifeMD's revenue fell $725K (-1%) from $50.9M in Q1 2025 to $50.2M in Q1 2026.
What drove LifeMD's revenue change in Q1 2026?
Telehealth −$1.0M (-5%); Telehealth Subscription Revenue +$280K (+0.9%).